Log in

NASDAQ:AXGTAxovant Gene Therapies News Headlines

$2.54
-0.11 (-4.15 %)
(As of 04/8/2020 02:55 AM ET)
Add
Compare
Today's Range
$2.42
Now: $2.54
$2.65
50-Day Range
$1.44
MA: $2.81
$4.51
52-Week Range
$1.41
Now: $2.54
$9.60
Volume44,813 shs
Average Volume229,337 shs
Market Capitalization$93.53 million
P/E RatioN/A
Dividend YieldN/A
Beta1.26

Headlines

Axovant Gene Therapies (NASDAQ AXGT) News Headlines

Source:
DateHeadline
Zacks: Brokerages Expect Axovant Gene Therapies Ltd (NASDAQ:AXGT) Will Post Earnings of -$0.59 Per ShareZacks: Brokerages Expect Axovant Gene Therapies Ltd (NASDAQ:AXGT) Will Post Earnings of -$0.59 Per Share
www.americanbankingnews.com - April 1 at 9:17 PM
Axovant to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease DayAxovant to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Day
finance.yahoo.com - March 31 at 11:34 AM
Axovant Gene Therapies Ltd.Axovant Gene Therapies Ltd.
www.fool.com - March 28 at 10:20 PM
Axovant Gene Therapies Ltd (NASDAQ:AXGT) Receives Consensus Rating of "Buy" from BrokeragesAxovant Gene Therapies Ltd (NASDAQ:AXGT) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - March 26 at 8:06 PM
Axovant Gene Therapies Ltd (NASDAQ:AXGT) Director Acquires $17,800.00 in StockAxovant Gene Therapies Ltd (NASDAQ:AXGT) Director Acquires $17,800.00 in Stock
www.americanbankingnews.com - March 19 at 5:43 AM
Does Market Volatility Impact Axovant Gene Therapies Ltd.s (NASDAQ:AXGT) Share Price?Does Market Volatility Impact Axovant Gene Therapies Ltd.'s (NASDAQ:AXGT) Share Price?
finance.yahoo.com - March 10 at 9:39 PM
Does Market Volatility Impact Axovant Gene Therapies Ltd.'s (NASDAQ:AXGT) Share Price?Does Market Volatility Impact Axovant Gene Therapies Ltd.'s (NASDAQ:AXGT) Share Price?
finance.yahoo.com - March 10 at 11:38 AM
Axovant Gene Therapies Announces Closing of $74.7 Million Public Offering of Common Shares and Prefunded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional SharesAxovant Gene Therapies Announces Closing of $74.7 Million Public Offering of Common Shares and Prefunded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - February 24 at 7:49 PM
Axovant Gene Therapies prices stock offering at $3.75Axovant Gene Therapies prices stock offering at $3.75
seekingalpha.com - February 20 at 9:16 AM
Axovant Gene Therapies down 11% after hours on equity offeringAxovant Gene Therapies down 11% after hours on equity offering
seekingalpha.com - February 19 at 11:09 PM
Axovant Gene Therapies Announces Pricing of $65 Million Public OfferingAxovant Gene Therapies Announces Pricing of $65 Million Public Offering
finance.yahoo.com - February 19 at 11:09 PM
Axovant Gene Therapies Announces Commencement of Public OfferingAxovant Gene Therapies Announces Commencement of Public Offering
finance.yahoo.com - February 19 at 6:08 PM
Passage Bio To IPO Soon, Promising Gene Therapy Pipeline Against Rare DiseasesPassage Bio To IPO Soon, Promising Gene Therapy Pipeline Against Rare Diseases
seekingalpha.com - February 14 at 2:23 PM
Axovant Announces Financial Results for Third Fiscal Quarter and Nine Months Ended December 31, 2019Axovant Announces Financial Results for Third Fiscal Quarter and Nine Months Ended December 31, 2019
finance.yahoo.com - February 10 at 8:02 AM
Axovant Gene Therapies Ltd. Common Shares (AXGT) Institutional HoldingsAxovant Gene Therapies Ltd. Common Shares (AXGT) Institutional Holdings
www.nasdaq.com - January 24 at 9:28 PM
Axovant Gene Therapies up 9% premarket on pipeline updateAxovant Gene Therapies up 9% premarket on pipeline update
seekingalpha.com - January 13 at 3:24 PM
Axovant Announces Positive 12-month Data on AXO-Lenti-PD and Provides Updates Across Gene Therapy Pipeline ProgramsAxovant Announces Positive 12-month Data on AXO-Lenti-PD and Provides Updates Across Gene Therapy Pipeline Programs
finance.yahoo.com - January 13 at 7:55 AM
What Makes Axovant (AXGT) a New Buy StockWhat Makes Axovant (AXGT) a New Buy Stock
finance.yahoo.com - January 6 at 5:05 PM
Axovant Gene Therapies Ltd. (AXGT): Hedge Funds In Wait-and-See ModeAxovant Gene Therapies Ltd. (AXGT): Hedge Funds In Wait-and-See Mode
finance.yahoo.com - December 23 at 5:42 PM
Axovant up 17% premarket on gene therapy data in rare nerve cell diseaseAxovant up 17% premarket on gene therapy data in rare nerve cell disease
seekingalpha.com - December 20 at 12:34 PM
The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Mercks Ebola Vaccine, Abeona Announces OfferingThe Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering
finance.yahoo.com - December 20 at 12:34 PM
Axovant's GM1 Gangliosidosis Candidate Gets Orphan Drug TagAxovant's GM1 Gangliosidosis Candidate Gets Orphan Drug Tag
finance.yahoo.com - November 19 at 12:17 PM
Axovant Gene Therapies Receives Orphan Drug Designation from FDA for AXO-AAV-GM1 for the Treatment of GM1 GangliosidosisAxovant Gene Therapies Receives Orphan Drug Designation from FDA for AXO-AAV-GM1 for the Treatment of GM1 Gangliosidosis
finance.yahoo.com - November 18 at 11:13 AM
Axovant Gene Therapies Enters Oversold TerritoryAxovant Gene Therapies Enters Oversold Territory
finance.yahoo.com - November 14 at 3:50 PM
Axovant (AXGT) Moves to Strong Buy: Rationale Behind the UpgradeAxovant (AXGT) Moves to Strong Buy: Rationale Behind the Upgrade
finance.yahoo.com - November 13 at 12:05 PM
Axovant Announces Corporate Updates and Financial Results for Second Fiscal Quarter Ended September 30, 2019Axovant Announces Corporate Updates and Financial Results for Second Fiscal Quarter Ended September 30, 2019
finance.yahoo.com - November 8 at 12:32 PM
Axovant Gene Therapies Announces Investor Conference Presentations for the Remainder of 2019Axovant Gene Therapies Announces Investor Conference Presentations for the Remainder of 2019
finance.yahoo.com - November 5 at 1:00 PM
AXGT Axovant Gene Therapies Ltd. Common SharesAXGT Axovant Gene Therapies Ltd. Common Shares
www.nasdaq.com - October 24 at 8:26 AM
Axovant up 15% premarket on encouraging Tay-Sachs gene therapy dataAxovant up 15% premarket on encouraging Tay-Sachs gene therapy data
seekingalpha.com - October 23 at 1:08 PM
Axovant Presents First Evidence of Clinical Stabilization in Tay-Sachs Disease at the European Society of Gene and Cell Therapy 27th Annual CongressAxovant Presents First Evidence of Clinical Stabilization in Tay-Sachs Disease at the European Society of Gene and Cell Therapy 27th Annual Congress
finance.yahoo.com - October 23 at 8:07 AM
Axovant Gene Therapies Announces Upcoming Presentations at the European Society of Gene and Cell Therapy 27th Annual CongressAxovant Gene Therapies Announces Upcoming Presentations at the European Society of Gene and Cell Therapy 27th Annual Congress
finance.yahoo.com - October 10 at 8:49 AM
Axovant (AXGT) Upgraded to Buy: Here's What You Should KnowAxovant (AXGT) Upgraded to Buy: Here's What You Should Know
finance.yahoo.com - October 9 at 12:42 PM
Axovant Gene Therapies to Present at 2019 Cell & Gene Meeting on the MesaAxovant Gene Therapies to Present at 2019 Cell & Gene Meeting on the Mesa
finance.yahoo.com - September 25 at 4:24 PM
Axovant (AXGT) Stock Moves -1.31%: What You Should KnowAxovant (AXGT) Stock Moves -1.31%: What You Should Know
finance.yahoo.com - September 19 at 8:55 PM
Axovant Gene Therapies Ltd. (NASDAQ:AXGT): What Does Its Beta Value Mean For Your Portfolio?Axovant Gene Therapies Ltd. (NASDAQ:AXGT): What Does Its Beta Value Mean For Your Portfolio?
finance.yahoo.com - September 12 at 11:49 AM
Axovant Analyst Turns Bullish Ahead Of Q4 Gene Therapy Data ReadoutsAxovant Analyst Turns Bullish Ahead Of Q4 Gene Therapy Data Readouts
finance.yahoo.com - August 13 at 12:51 AM
Axovant Announces Corporate Updates and Financial Results for First Fiscal Quarter Ended June 30, 2Axovant Announces Corporate Updates and Financial Results for First Fiscal Quarter Ended June 30, 2
www.nasdaq.com - August 10 at 9:11 AM
Axovant Announces Corporate Updates and Financial Results for First Fiscal Quarter Ended June 30, 2019Axovant Announces Corporate Updates and Financial Results for First Fiscal Quarter Ended June 30, 2019
finance.yahoo.com - August 9 at 3:36 PM
Immunomedics (IMMU) Posts Wider-Than-Expected Loss in Q2Immunomedics (IMMU) Posts Wider-Than-Expected Loss in Q2
finance.yahoo.com - August 8 at 3:36 PM
Catalyst's (CPRX) Q2 Earnings and Revenues Beat EstimatesCatalyst's (CPRX) Q2 Earnings and Revenues Beat Estimates
finance.yahoo.com - August 8 at 11:31 AM
Horizon Therapeutics' (HZNP) Q2 Earnings Beat EstimatesHorizon Therapeutics' (HZNP) Q2 Earnings Beat Estimates
finance.yahoo.com - August 8 at 11:31 AM
Geron (GERN) Stock Up Despite Q2 Earnings & Sales MissGeron (GERN) Stock Up Despite Q2 Earnings & Sales Miss
finance.yahoo.com - August 2 at 3:35 PM
Axovant (AXGT) Gains As Market Dips: What You Should KnowAxovant (AXGT) Gains As Market Dips: What You Should Know
finance.yahoo.com - July 29 at 8:46 PM
Eton's Ophthalmic Solution Candidate Gets CRL, Shares FallEton's Ophthalmic Solution Candidate Gets CRL, Shares Fall
finance.yahoo.com - July 16 at 10:07 AM
Axovant (AXGT) Outpaces Stock Market Gains: What You Should KnowAxovant (AXGT) Outpaces Stock Market Gains: What You Should Know
finance.yahoo.com - July 13 at 10:18 AM
Will Axovant Sciences Continue to Surge Higher?Will Axovant Sciences Continue to Surge Higher?
finance.yahoo.com - July 10 at 9:55 AM
Sarepta Stock Up Almost 40% This Year So Far: Here's WhySarepta Stock Up Almost 40% This Year So Far: Here's Why
finance.yahoo.com - July 8 at 3:28 PM
Perrigo Completes Ranir Acquisition, Raises '19 GuidancePerrigo Completes Ranir Acquisition, Raises '19 Guidance
finance.yahoo.com - July 3 at 3:29 PM
Axovant Appoints David Nassif as Chief Financial Officer and Expands Board of DirectorsAxovant Appoints David Nassif as Chief Financial Officer and Expands Board of Directors
finance.yahoo.com - July 1 at 9:32 AM
Is Axovant Gene Therapies Ltd. (AXGT) Going to Burn These Hedge Funds?Is Axovant Gene Therapies Ltd. (AXGT) Going to Burn These Hedge Funds?
finance.yahoo.com - June 29 at 8:51 AM
This page was last updated on 4/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel